Enveda Biosciences
Founded 2019 · 382 employees on LinkedIn · 4 known investors
Enveda operates a drug discovery platform that reads and translates the chemistry of natural molecules to identify new medicines faster than industry averages. It serves pharmaceutical drug discovery by mapping the chemical composition of the natural world for therapeutic development.
Founders & leadership
Enveda Biosciences was founded in 2019 by Viswa Colluru, PhD.
VC
Viswa Colluru, PhDinFounderViswa Colluru, PhD, is the founder of Enveda Biosciences, which operates a drug discovery platform that maps the molecular patterns behind medicinal plants to identify new therapeutics. He was previously an early team member at Recursion, where he worked as an innovation scientist, discovery product manager, and on commercial strategy for drug candidates, and during graduate school developed three technologies aimed at improving immune-based cancer therapies.
Investors · 4
Funding
SEC filings, press & company announcements$150M disclosed across 1 of 2 rounds · 2024–2025
- $150MSeries DSep 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Enveda’s exercise-simulating obesity tablet clears early clinical test - BioSpacebiospace.com · Aug 2026Frequently asked questions
- What does Enveda Biosciences do?
- Enveda operates a drug discovery platform that reads and translates the chemistry of natural molecules to identify new medicines faster than industry averages. It serves pharmaceutical drug discovery by mapping the chemical composition of the natural world for therapeutic development.
- Who founded Enveda Biosciences?
- Enveda Biosciences was founded by Viswa Colluru, PhD in 2019.
- Who are Enveda Biosciences's investors?
- Enveda Biosciences's investors include JAZZ Venture Partners, Lux Capital, Village Global, Wireframe Ventures.
- How much funding has Enveda Biosciences raised?
- Enveda Biosciences has disclosed $150M raised across 1 of its 2 known rounds.